ArticleCell reports. Medicine2024

Inhibition of CD38 enzymatic activity enhances CAR-T cell immune-therapeutic efficacy by repressing glycolytic metabolism.

Yue Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.